MEDS2TRACE LIMITED

Company Registration Number:
15825674 (England and Wales)

Unaudited micro entity accounts for the year ended 31 July 2025

Period of accounts

Start date: 08 July 2024

End date: 31 July 2025

MEDS2TRACE LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

MEDS2TRACE LIMITED

Company Information

for the Period Ended 31 July 2025




Director: Sean Fuller
Registered office: 18
Drake Close
Barking Essex
London
County
GBR
IG11 0FH
Company Registration Number: 15825674 (England and Wales)

MEDS2TRACE LIMITED

Directors' Report Period Ended 31 July 2025

The directors present their report with the financial statements of the company for the period ended 31 July 2025

Principal Activities

Startup which provides medication digital administration ensuring accuracy for patient safety. We have been doing test over the period and have not been able to gain any revenue except from grants provided by Big Issue Invest and LSBU.

Political and charitable donations

There were no political or charitable donation over the period to report.

Company policy on the employment of disabled persons

We embrace people with disability and the core of the tech application is to support people with disability who take medication in the community. We are keen to support disability employees, and we are keen to support them live health lives and as well earn a living to support themselves.

Additional information

N/A

Directors

The director(s) shown below were appointed to the company during the period
Sean Fuller
08 July 2024

This report was approved by the board of directors on 26 September 2025
And Signed On Behalf Of The Board By:

Name: Sean Fuller
Status: Director

MEDS2TRACE LIMITED

Profit and Loss Account

for the Period Ended 31 July 2025

13 months to
31 Jul 2025
£
Turnover 11,592
Staff Costs ( 5,500 )
Depreciation and Writeoffs ( 318 )
Other charges ( 6,091 )
Profit or (Loss) for Period ( 317 )

MEDS2TRACE LIMITED

Balance sheet

As at 31 July 2025

13 months to
31 Jul 2025
£
Called up share capital not paid: 0
Fixed Assets: 501,271
Current assets: 409
Creditors: amounts falling due within one year: ( 0 )
Net current assets (liabilities): 409
Total assets less current liabilities: 501,680
Creditors: amounts falling due after more than one year: ( 114,000 )
Total net assets (liabilities): 387,680
Capital and reserves: 387,680

MEDS2TRACE LIMITED

Balance sheet continued

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 26 September 2025
And Signed On Behalf Of The Board By:

Name: Sean Fuller
Status: Director

The notes form part of these financial statements

MEDS2TRACE LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 July 2025

  • 1. Employee Information

    Average number of employees: 4

MEDS2TRACE LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 July 2025

  • 2. Off balance sheet disclosure

    No